Archive
Small cap movers: Novacyt rare riser thanks to coronavirus test
A look back at some of the more interesting stories from London's junior market this week
Company
Novacyt SA
LON:NCYT
Novacyt SA is an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialisation, contract design and manufacturing. The company's lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high-quality assays and reagents worldwide. Novacyt directly serves microbiology, haematology and serology markets as do its global partners, which include major corporates.
24 stories · page 2 of 2
Archive
On the Beach issues profit warning as travel customers get leery
A look at some of the major movers in the market on Friday
Small cap movers: Novacyt enjoys “unprecedented interest” in coronavirus test
A look back at some of the more interesting stories from London's junior market this week
Novacyt reports unprecedented interest in coronavirus diagnostic launched just a week ago
Its unit Primedesign has already received orders for 33,000 tests and requests for quotations for another 32,000 from over 30 countries